Catherine J. Mackey - 05 Apr 2022 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Director
Signature
/s/ Jason Throne, as Attorney-in-Fact for Catherine J. Mackey
Issuer symbol
IDYA
Transactions as of
05 Apr 2022
Net transactions value
$0
Form type
4
Filing time
06 Apr 2022, 16:23:01 UTC
Previous filing
16 Dec 2021
Next filing
16 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (Right to Buy) Award $0 +22,000 $0.000000 22,000 05 Apr 2022 Common Stock 22,000 $11.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option vest on each monthly anniversary measured from April 5, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.